(Press-News.org) Philadelphia, PA, 18 January 2011 - Biological Psychiatry is proud to announce this week's publication of a special issue focusing on postmortem studies of psychosis.
This special issue showcases the use of human brains postmortem to study psychiatric disorders, focusing on schizophrenia. The review articles highlight the benefits, achievements, problems, and perhaps most importantly, the future of postmortem research.
Postmortem research, which allows scientists to study the brain directly via its tissue, is difficult and expensive. Hence, it is a relatively rare avenue of research into brain disorders. Instead, such research more often focuses on studying the brain indirectly by using specialized imaging techniques, animal models, or blood markers.
However, the inherent difficulties of postmortem research can be overcome. Standards of tissue quality have been developed and are now commonly accepted. Brain banks have steadily increased their collections, increasing study sample sizes and thereby the robustness of their findings.
Advances in science and specialized techniques over recent years have also expanded the scope of the work that can be accomplished using postmortem brain tissue. In addition to structural distinctions, cellular, molecular, and genetic findings can be identified using a postmortem research approach.
Postmortem studies of brain have already contributed to our understanding of diseases such as schizophrenia, and will continue to do so. For example, critical work has already shown how brains from people with schizophrenia differ in terms of structure and function, and how the genes which contribute to causing these illnesses affect the brain.
Although these articles focus primarily on psychosis, postmortem work has the ability to shed light on a wide range of psychiatric disorders, including Alzheimer's disease and depression.
###
Biological Psychiatry will continue to welcome high quality research papers in this field.
Notes to Editors:
The discussed issue is Biological Psychiatry, Volume 69, Number 2 (January 15, 2011), published by Elsevier. The issue is entitled "Postmortem Studies of Psychosis: Status, Opportunities, and Challenges."
Contact Chris J. Pfister at c.pfister@elsevier.com to obtain a copy or to schedule an interview.
About Biological Psychiatry
This international rapid-publication journal is the official journal of the Society of Biological Psychiatry. It covers a broad range of topics in psychiatric neuroscience and therapeutics. Both basic and clinical contributions are encouraged from all disciplines and research areas relevant to the pathophysiology and treatment of major neuropsychiatric disorders. Full-length reports of novel results, commentaries, case studies of unusual significance, and correspondence judged to be of high impact to the field are published, particularly those addressing genetic and environmental risk factors, neural circuitry and neurochemistry, and important new therapeutic approaches. Concise reviews and editorials that focus on topics of current research and interest are also published rapidly.
Biological Psychiatry (www.sobp.org/journal) is ranked 4th out of 117 Psychiatry titles and 13th out of 230 Neurosciences titles in the 2009 ISI Journal Citations Reports® published by Thomson Reuters. The 2009 Impact Factor score for Biological Psychiatry has increased to 8.926.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
END
Developing new drugs is a highly costly and time-consuming process. Of 20 candidates, 19 are normally rejected because they don't work or have unwanted side effects. Now a research team led by Professor Lars Baltzer at Uppsala University has produced a tiny molecular "binder" that has the potential to change this landscape radically.
The study, published today in the prestigious journal Angewandte Chemie, presents the concept of a tiny polypeptide consisting of 42 amino acids to which virtually any target-seeking organic molecule can be bound. In the body it then seeks ...
WASHINGTON -- The first global simulation study of equatorial spread F (ESF) bubble evolution using a comprehensive 3D ionosphere model, SAMI3, has been demonstrated. The model self-consistently solves for the neutral wind driven dynamo electric field and the gravity driven electric field associated with plasma bubbles.
Developed by Dr. Joseph Huba and Dr. Glenn Joyce at the NRL Plasma Physics Division, SAMI3 is a fully three-dimensional model of the low- to mid-latitude ionosphere. SAMI3 has been modified recently to use a sun-fixed coordinate system to eliminate rotation ...
Nutrients, vitamins, minerals – during pregnancy a woman's body needs more of them. For most nutrients this increase in demand can be covered with a balanced diet. However, mothers-to-be should ingest some nutrients in the form of tablets. Research conducted by the Chair of Nutritional Medicine at the Technische Universitaet Muenchen (TUM) indicates there are knowledge gaps: According to this study, pregnant women often start taking sensible dietary supplements too late or not at all. At the same time, other micronutrients are unwittingly overdosed whose effects during ...
Researchers at the University of Warwick have developed the world's first complete High Dynamic Range (HDR) video system, from video capture to image display, that will help a range of users including: surveillance camera operators, surgeons using video to conduct or record surgery, and camera crews following a football being kicked from sunshine into shadow.
The researchers will be premiering footage of the world's first ever showing of a short film shot using this new HDR technology in the WMG Digital Laboratory at the University of Warwick on Wednesday January 19 ...
Controlling blood pressure is not only a medical challenge, but a social one as well. Because patients are required to strictly adhere to a treatment plan that may include medication, dietary restrictions and regular doctor visits, the ideas of wellness and health are also powerful parts of the social reinforcement needed for behavioral change.
This is especially true in the African American population, which is particularly susceptible to hypertension. Social and cultural barriers have been found to contribute to African American patients being far more likely than white ...
New research by a team of psychologists from Canada, Belgium, and the United States shows there is more than a literal truth to the saying that 'you never get a second chance to make a first impression'. The findings suggest that new experiences that contradict a first impression become 'bound' to the context in which they were made. As a result, the new experiences influence people's reactions only in that particular context, whereas first impressions still dominate in other contexts.
"Imagine you have a new colleague at work and your impression of that person is not ...
Boston, Mass. — Following a successful Phase 1 study for safety, researchers at MassBiologics of the University of Massachusetts Medical School (UMMS) today announced the beginning of a Phase 2 clinical trial testing the ability of a human monoclonal antibody they developed to prevent hepatitis C virus (HCV) infection of a donor liver in transplant patients.
The first patients were enrolled in the study in December. The primary goal of this randomized, double-blind, placebo-controlled study is to test if the monoclonal antibody, designated MBL-HCV1, prevents re-infection ...
Montreal, January 18, 2011 – Does experience give seniors an edge in reacting to sudden change or are younger people quicker to respond? A new study from Concordia University shows that when a routine task is interrupted by an unexpected event, younger adults are faster at responding. Published in the Journal of Gerontology, the findings have implications for educators and for older adults in situations where performance is crucial.
"When we frequently perform a task, our reactions become automatic," says Kevin Trewartha, first author and a PhD student in Concordia's ...
Key components of the ESA-led Mercury mapper BepiColombo have been tested in a specially upgraded European space simulator. ESA's Large Space Simulator is now the most powerful in the world and the only facility capable of reproducing Mercury's hellish environment for a full-scale spacecraft.
The Mercury Magnetospheric Orbiter (MMO) has survived a simulated voyage to the innermost planet. The octagonal spacecraft, which is Japan's contribution to BepiColombo, and its ESA sunshield withstood temperatures higher than 350°C.
This is a taste of things to come for the ...
Montreal, January 18, 2011 – Cyndia Charfi, a Ph. D student in biology at Université du Québec à Montréal (UQAM), supported by her thesis supervisors, Professor Éric Rassart, and Adjunct Professor Elsy Edouard, UQAM, Department of Biological Sciences and BIOMED Research Centre, made a major breakthrough in research on B-cell acute lymphocytic leukemia, a disease that occurs most commonly in children. She has successfully identified a gene that may facilitate the diagnosis of this cancer, which is characterized by an abnormal proliferation of B-cells, antibody-producing ...
